Biofrontera
BFRI
Biofrontera (BFRI) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Benchmark | Downgraded | Buy → Speculative Buy | $3.00 | May 19, 2026 |
| Benchmark | Maintained | Buy | $2.75 from $7.00 | May 19, 2025 |
| Benchmark | Maintained | Buy | $7.00 | Nov 15, 2024 |
| Benchmark | Maintained | Buy | $7.00 | Aug 16, 2024 |
| Benchmark | Maintained | Buy | $18.00 | Aug 31, 2023 |
| Benchmark | Maintained | Buy | $18.00 from $140.00 | Jul 5, 2023 |
| Benchmark | Maintained | Buy | $7.00 | May 15, 2023 |
Frequently asked questions
What is the latest analyst rating on BFRI?
On May 19, 2026, Benchmark downgraded Biofrontera to Speculative Buy with a price target of $3.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.